Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Saptausaha Gemilangindah Tbk. (SAGE) Price & Performance

UBC Medical Indonesia Tbk.Trade
Saptausaha Gemilangindah Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Saptausaha Gemilangindah Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp166 (market cap 651.75B, 45.1K 24h volume), while Saptausaha Gemilangindah Tbk. trades at Rp32 (market cap 257.07B). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.5× Saptausaha Gemilangindah Tbk.'s market cap. Which is the better fit depends on your goals.

LABSSAGE
Market Cap
651.75B257.07B
Volume
45.1K
Lot
451
Turnover
7.44M
Average Price
165.07
Value
7.44M
Indicative Equilibrium Price
16532
Indicative Equilibrium Volume
3003.87K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
SAGE
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Saptausaha Gemilangindah Tbk.

PT Saptausaha Gemilangindah Tbk (the Company) was established on July 29, 1992 based onNotarial Deed No. 63 of Sulaimansjah, S.H., notary in Jakarta. The Company started its commercial operations on 2017.

Read more on SAGE